We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Neon Healthcare Ltd is recalling the specific batch mentioned in this notification as a precautionary measure.
medac GmbH (t/a medac Pharma LLP) is recalling the product for the batch specified in this notification due to particles detected during long-term stability tests.
A. Menarini Farmaceutica Internazionale Srl is recalling a specific batch as a precautionary measure due to the distribution of Invokana 300mg in Northern Ireland in packaging intended for the Greek market.
Safety leaflet on topical corticosteroids and withdrawal reactions to help patients and their carers to use these medicines safely.
This guide is about infections that occur in people who inject drugs (PWID).
Orifarm UK has informed the MHRA of an error with the Patient Information Leaflet (PIL) packaged within the parallel import packs of the specific batches of Concerta XL 18mg and 36mg prolonged release tablets mentioned in this notification.
Product Safety Report for Esapharma Movate Steroid Cream presenting a serious chemical risk.
New warnings and contraindications for ergot-derived dopamine agonists due to risk of fibrosis associated with chronic use.
Employment Appeal Tribunal Judgment of Judge Tayler on 12 April 2024.
Check the tariff classification for surface-active preparation for washing the skin and the hair (gel 2-in-1).
Incident planning for potent synthetic opioids arriving into the illicit drug market.
medac GmbH (t/a medac Pharma LLP) is recalling the products and respective batches in this notification due to pink discolouration of the dacarbazine solution immediately after reconstitution (after correct preparation and storage).
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
The MHRA has reviewed the latest evidence relating to the very rare risk of PRES and RCVS associated with medicines containing pseudoephedrine
Product Safety Report for Aliex 4-in-1 Montessori Toy presenting a serious risk of choking.
Laboratories can use this template to notify a GP or child health records department (CHRD) that a child's blood spot screen for cystic fibrosis (CF) is not complete.
medac GmbH (t/a medac Pharma LLP) is recalling further batches due to particles detected during long-term stability tests.
Atnahs Pharma UK Ltd has informed the MHRA that the batches of Clobazam Atnahs 5mg/5ml and 10mg/5ml Oral Suspension listed in this notification do not contain the most up to date safety information.
What you need to do to trade ozone-depleting substances (ODS) between Great Britain (England, Scotland and Wales) and Northern Ireland.
Recommendations for a temporary class drug order on a number of methylphenidate-based novel psychoactive substances.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.